Detection of telomerase activity and the expression of telomerase subunits in the patients with acute myelogenous leukaemia

Abstract

Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML, including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively. The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation. AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3% and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the upregulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.

Keywords

acute myelogenous leukaemia / telomerase / telomerase reverse transcriptase / telomerase associated protein 1 / telomerase RNA component

References

[1] NakamuraT M, MorinG B, ChapmanK B, et al.. Telomerase catalytic subunit homologs from fission yeast and human [see comments]. Science, 1997, 277: 955-955

[2] MeyersonM, CounterC M, EatonE N, et al.. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 1997, 90: 785-785

[3] HahnW C, StewartS A, BrooksM W, et al.. Inhibition of telomerase limits the growth of human cancer cells. Nature Medicine, 1999, 5: 1164-1164

[4] TohruS, YasushiS, TomoakiF. Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer. J Urol, 1999, 162: 2217-2217

[5] BarbaraA K, PeterT R. Telomere-related components are coordinately synthesized during human T-lymphocyte activation. Leukemia Res, 1999, 23: 1097-1097

[6] IvanB, CatherineN, ValerieP, et al.. Quantitation of HTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Can Res, 2000, 6: 452-452

[7] CounterC M, HirteH W, BacchettiS, et al.. Telomerase activity in human ovarian carcinoma. Proc Nat Acad Sci, 1994, 91: 2900-2900

[8] HarleyC B, KimN W, ProwseK R, et al.. Telomerase, immoratality and cancer. Cold Spring Harb Symp Quant Biol, 1994, 59: 307-307

[9] FlintJ, CarddockC F, VillegasA, et al.. Healing of broken human chromosomes by addition of telomeric repeats. Am J Hum Genet, 1994, 55: 505-505

[10] HarringtonL A, GreiderC W. Telomerase prime specificity and chromosome healing. Nature, 1991, 353: 451-451

[11] DaweiX, AsteridG. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol, 1998, 102: 1367-1367

[12] ToshikuniN, NousoK, HigashiT, et al.. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. Br J Cancer, 2000, 82: 833-833